GORDON HENDRICKSON: Open Payments
NPI 1538877071 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 82 payments from 28 companies in 2025. Trend: 2023 $2,091 · 2024 $1,963 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $256 |
| Novartis Pharmaceuticals Corporation | 9 | $247 |
| PFIZER INC. | 8 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $120 |
| Corcept Therapeutics | 4 | $93 |
| Lilly USA, LLC | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Amgen Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Novo Nordisk Inc | 3 | $53 |
Products named: LEQVIO, XIFAXAN, Korlym, ELIQUIS, BREZTRI, AIRSUPRA, REXULTI, Kerendia.
Industry payments across WY — which companies pay providers there.
